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AB STRACT 
Mutations in the visual photoreceptor rhodopsin are the cause of the retinal degenerative 
disease retinitis pigmentosa. Some naturally-occurring mutations can lead to protein 
conformational instability. Two such mutations, N55K and G90V, in the first and 
second transmembrane helices of the receptor, have been associated with sector and 
classical retinitis pigmentosa respectively, and showed enhanced thermal sensitivity. 
We have carefully analyzed the effect of phospholipid bicelles on the stability and 
ligand-binding properties of these two mutants and compared it with those of the 
detergent-solubilized samples. We have used a phospholipid bilayer constituted of 1,2-
dimyristoyl-sn-glycero-3-phosphatidylcholine (DMPC) and 1,2-dihexanoyl-sn-glycero-
3-phosphocholine (DHPC) bicelles system. We find that DMPC/DHPC bicelles 
dramatically increase the thermal stability of the rhodopsin mutants G90V and N55K. 
The chromophore stability and regeneration of the mutants were also increased in 
bicelles when compared to their behavior in dodecyl maltoside detergent solution. The 
retinal release process was slowed down in bicelles and chromophore entry, after 
illumination, was improved for the G90V mutant but not for N55K.  Furthermore, 
fluorescence spectroscopy measurements showed that bicelles allowed more exogenous 
retinal binding to photoactivated G90V mutant than in detergent solution. In contrast, 
N55K could not re-position any chromophore either in detergent or in bicelles. The 
results demonstrate that DMPC/DHPC bicelles can counteract the destabilizing effect of 
the disease-causing mutations and can modulate the structural changes ensuing receptor 
photoactivation in a distinct specific manner for different retinitis pigmentosa mutant 
phenotypes.   
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ABBREVIATIONS 
GPCRs, G-protein-coupled receptors; RP, retinitis pigmentosa; sector RP, sector 
retinitis pigmentosa; ROS, rod outer segment; Rho, rhodopsin; WT, wild type;  DMPC, 
1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine; DHPC, 1,2-dihexanoyl-sn-glycero-
3-phosphocholine; DM, n-dodecyl-D-maltoside; SB, Schiff base; BTP, bis-tris-propane; 
SDS-PAGE, SDS polyacrylamide gel electrophoresis; MetaII,  Metarhodopsin II. 
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INTRODUCTION 
The visual photoreceptor rhodopsin (Rho) is a prototypical member of the G-protein-
coupled receptors (GPCRs) superfamily responsible for scotopic (or dim-light) vision. 
As a model of GPCRs, Rho has been extensively studied, and since the first report of its 
crystal structure, several GPCRs structures have been solved by X-ray crystallography 
1–5. Rho is found in the rod outer segment (ROS) membranes of the photoreceptor cells 
of the retina where it is embedded in the lipid bilayer surrounded by ~65-70 
phospholipids per protein molecule 6–9. Rho consists of the opsin apoprotein and the 11-
cis-retinal ligand which is covalently bound through a protonated Schiff base (SB) 
linkage to K296 at the seventh transmembrane helix of the photoreceptor 10–12. Upon 
photon absorption, the 11-cis retinal chromophore isomerizes to all-trans-retinal and 
triggers a conformational change in the receptor that leads to the active metarhodopsin 
II (MetaII) photointermediate which can bind and activate the G-protein transducin 11,13. 
Mutations in Rho are one of the main causes of retinitis pigmentosa (RP), which is a 
genetically heterogeneous disorder involving rod photoreceptor cell death and 
eventually leading to blindness 14. The worldwide prevalence of RP is about one in 4000 
10,15. Misfolding and misassembly of mutant Rho, associated with RP, alters the cellular 
fate and induces cell death 16,17. Some mutations alter the trafficking ability from the 
endoplasmic reticulum to the plasma membrane 18. Sector retinitis pigmentosa (sector 
RP) is an atypical variant of RP. In sector RP, only isolated areas of the fundus show 
pigmentary changes. It is characterized by regionalized areas of bone spicule 
pigmentation usually found in the inferior quadrants of the retina, abnormal electro-
retinograms, visual-field defects, and slow to no degeneration 19.  
Structure-function studies of Rho are typically carried out in the mild dodecyl maltoside 
(DM) detergent solution 20,21. However, membrane proteins often show poor 
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conformational stability, and can lose activity or even denature in detergent micelles 
22,23. Membrane-like environments help maintaining the proper structure and 
biochemical function of membrane proteins and their mutants 24,25. Phospholipid 
bicelles have been shown to improve the stability of Rho 26–28, and for this reason we 
have studied two Rho mutants, G90V and N55K, and compared their properties in DM 
detergent and in DMPC/DHPC bicelles (Figure 1). G90V (causing RP phenotype) and 
N55K (associated with sector RP) show structural instability in the dark and thermal 
sensitivity 21,29,30. 9-cis-retinal was used as an exogenous analog 31,32 for a detailed 
characterization of these two specific Rho mutants. The thermal stability and 
chromophore regeneration ability of G90V and N55K improved in DMPC/DHPC 
bicelles, which provided a suitable bilayer environment for the mutants. MetaII decay 
experiments of G90V mutant in bicelles showed additional fluorescence increase upon 
hydroxylamine addition after complete retinal release but not for the N55K mutant. This 
suggested conformational differences in the photoactivated receptors affecting retinal 
accessibility to the post-bleached opsin retinal-binding pocket.  Furthermore, the 
photoactived opsin conformation of the G90V RP mutant would be more efficient in 
allowing retinal entering into the opsin binding pocket when the protein is in  
DMPC/DHPC bicelles than when it is in DM detergent solution. In contrast, N55K 
opsin, in DMPC/DHPC bicelles, did not allow any chromophore entrance in the opsin 
binding pocket. Overall, the results obtained indicate that DMPC/DHPC bicelles offer a 
stable bilayer environment for mutants associated with RP but specific conformational 
differences can be observed for the two mutants, especially after photoactivation, which 
could be related to their different clinical phenotypes. 
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EXPERIMENTAL PROCEDURES 
Materials 
Rho was purified from bovine retinas, which were obtained from J.A. Lawson (Lincoln, 
NE). WT, G90V and N55K opsin genes were cloned into the pMT4 vector. The 
chromophore 11-cis-retinal was provided by Dr. R. Crouch (National Eye Institute, 
National Institutes of Health, USA). 9-cis-retinal was purchased from Sigma-Aldrich. 
1,2-dimyristoyl-sn-glycero-3-phosphocholine, DMPC(14:0) and 1,2-dihexanoyl-sn-
glycero-3-phosphocholine, DHPC(6:0) were purchased from Avanti Polar Lipids Inc 
(Alabaster, AL, USA) and n-dodecyl-D-maltoside (DM) was from Anatrace (Maumee, 
OH, USA). 
Purified mAb rho-1D4 was provided by Cell Essentials (Boston, MA, USA) and was 
coupled to CNBr-activated Sepharose 4B Fast Flow following the manufacturer’s 
instructions (Amersham Biosciences, USA). Secondary antibody goat anti-mouse IgG-
HRP conjugated was purchased from Santa Cruz Biotechnology (Heidelberg, Germany). 
The 1D4 9-mer peptide corresponding to the last 9 amino acids of Rho (TETSQVAPA) 
was synthesized by Serveis Cientificotècnics (Universitat de Barcelona, Spain). 
Hydroxylamine, protease inhibitor cocktail, phenylmethanesulfonyl (PMSF), and bis-
tris-propane (BTP) were from Sigma-Aldrich (St. Louis, MO, USA). Polyethyleneimine 
25 kDa (PEI) was purchased from Polysciences (Warrington, PA, USA).  
 Buffers 
The following buffers were used: buffer A: 10 mM bis-tris-propane (BTP), 140 mM 
NaCl, 2mM MgCl2, 2 mM CaCl2, pH 6.0; DM buffer: buffer A containing 0.05% (w/v) 
DM; bicelles buffer: buffer A containing 2% (w/v) DMPC/DHPC bicelles; solvent 
buffer: 137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, and 8 mM Na2HPO4, pH 7.4. 
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Cell culture materials 
COS-1 cells were obtained from the American Type Culture Collection (Manassas, VA, 
USA). DMEM, serum and antibiotics were from Sigma-Aldrich (St. Louis, MO, USA), 
OPTIMEM reduced serum media was from Life Technologies (Madrid, Spain).  
Bicelles preparation 
A 10% (w/v) DMPC sample was prepared by dissolving the powder in buffer A and 
gently vortexing, followed by incubating the solution at 42°C for 5 min and then 
cooling to room temperature. 10% (w/v) DHPC was also prepared in buffer A. Final 2% 
(w/v) DMPC/DHPC (1:1) mixtures were mixed briefly, heated to 42°C for 10 min, and 
then left to stir at room temperature for 1 h until the mixtures were clear (bicelles 
buffer). All bicelles solutions were used within 36 h from preparation 26. 
Expression, purification and preparation of Rho, and recombinant WT and mutants 
Rho refers to native Rho purified from bovine retinas whereas WT refers to 
recombinant Rho heterologously expressed in COS-1 cells, immunopurified and 
regenerated with 9-cis- retinal.  
Rho purification. ROS membranes were purified from bovine retinas using a sucrose 
gradient method under dim red light. The membranes were suspended in 70 mM 
potassium phosphate, 1mM MgCl2, 0.1mM EDTA, pH 6.9, then subsequently 
centrifuged and the pellets were resuspended in 5 mM Tris-HCl (pH 7.5) containing 0.5 
mM MgCl2. Two alternating washes with these buffers were carried out to remove any 
further contaminating proteins. Finally, ROS membranes were split into several aliquots 
and stored in the dark at -20°C. The ROS membranes were used for Rho purification. 
ROS membranes were solubilized in solvent buffer with 1% (w/v) DM in the dark for 1 
h at 4°C. Then the sample was centrifuged at 35000 rpm (50 Ti rotor) for 30 min at 4°C 
in order to get rid of any unsolubilized material. The soluble fraction was incubated 
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with the 1D4-Sepharose beads for 3 h and the purified protein was eluted in either DM 
buffer or bicelles buffer containing 100 μM 1D4 9-mer peptide. All the procedures were 
performed in the dark on ice. 
WT, and G90V and N55K mutants purification. WT opsin, and G90V and N55K 
mutants were constructed on a synthetic bovine opsin gene in the pMT4 vector 33. The 
WT, and the G90V and N55K opsin mutants were transiently expressed in COS-1 cells 
by chemical transfection using PEI reagent as previously described 34,35. After 48 h, the 
cells were harvested and regenerated with 10 μM 9-cis-retinal in solvent buffer with 
overnight incubation. Then the intact cells were solubilized in solvent buffer with 1% 
DM(w/v) containing 100 µM PMSF and protease inhibitors, followed by 
ultracentrifugation for 30 min in an Optima LE-80K Ultracentrifuge (Beckman Coulter) 
at 30,000 rpm (50 Ti rotor). The supernatants were used for immunoaffinity 
chromatography purification with Sepharose coupled to rho-1D4 antibody. The 
pigments were eluted, three hours after incubation, with 100 μM 1D4 9-mer peptide in 
DM buffer or in bicelles buffer. All the procedures were performed in the dark on ice. 
The samples in DM buffer and bicelles buffer were stored on ice and used within 36 h.  
UV-visible absorption and fluorescence spectroscopies  
UV-vis spectra were obtained with a Cary 100Bio spectrophotometer (Varian, 
Australia), equipped with water-jacketed cuvette holders connected to a circulating 
water bath. Temperature was controlled by a Peltier accessory connected to the 
spectrophotometer. All spectra were recorded in the 250nm-650nm range with a 
bandwidth of 2nm, a response time of 0.1s, and a scan speed of 300nm/min. The 
spectral ratio is defined as the absorbance at 280nm divided by the absorbance at the 
visible λmax value in order to measure the pigment yield and the chromophore stability 
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after purification. These samples were used for photobleaching, thermal bleaching, 
chromophore regeneration, MetaII decay and chromophore entry experiments. 
All fluorescence assays were performed by using a Photon Technologies QM-1 steady-
state fluorescence spectrophotometer (PTI Technologies, Birmingham, NJ, USA). 
Sample temperature was controlled with a TLC 50 Peltier accessory (Quantum 
Northwest, Liberty Lake, WA, USA) connected to a hybrid liquid coolant system 
Reserator XT (Zalman, Garden Grove, CA, USA). Trp fluorescence was monitored over 
time. All fluorescence scans were carried out by exciting the samples for 2s at 295nm 
with a slit of 0.5nm, and blocking the excitation beam for 28s with a beam shutter to 
avoid photobleaching of the sample. Trp emission was monitored at 330 nm with a slit 
of 10nm. 
Western blot of WT and mutants in DM detergent and in bicelles 
WT, G90V and N55K mutants were purified as described in either DM buffer or 
bicelles buffer. Then, 100 ng of purified protein were mixed with loading buffer and 
loaded onto a SDS-PAGE gel. After electrophoresis, the proteins were transferred to a 
nitrocellulose membrane and the protein bands visualized with the appropriate 
antibodies. Rho 1D4 antibody dilution of 1:10,000 was used for opsin detection and the 
secondary antibody was goat anti-mouse HRP with a 1:5,000 dilution. Both antibodies 
were dissolved in TBS with 0.1% (v/v) Tween buffer. Blots were developed using 
super-signal west pico chemiluminescent substrate (Thermo Fisher Scientific, USA).  
Thermal bleaching assay of the purified proteins 
The thermal stability of Rho, WT and its mutants was followed by means of UV-visible 
spectrophotometry. Pigment thermal bleaching rates were obtained, in the dark, by 
monitoring the decrease of absorbance at λmax of the visible spectral band as a function 
of time at either 55°C or 37°C. Spectra were recorded every min. Data points were 
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obtained by using the equation:A= (A-Af)/(A0-Af), where A is the absorbance recorded 
at λmax, Af  is the absorbance at the final time, and A0 is the absorbance at time 0. The 
half-life time (t1/2) for the process was determined by fitting the experimental data to 
single exponential decay curves using Sigma Plot version 11.0 (Systat Software, 
Chicago, IL, USA). 
Regeneration of WT, G90V and N55K 
2.5 fold molar excess of 9-cis-retinal was added to the purified samples, in the dark, 
followed by illumination with a 150-watt power source equipped with an optic fiber 
guide, using a >495 nm cut-off filter to avoid photobleaching of the free retinal. The 
samples were illuminated for 30s at 20°C and spectra were recorded every min until no 
further increase at Aλmax was detected. 
MetaII decay measurements  
The MetaII active conformation decay process was followed in real time by 
fluorescence spectroscopy as previously described 36. Briefly, 0.5µM Rho in DM buffer, 
or bicelles buffer, was allowed to stabilize for 10min at 20°C in the fluorimeter, and the 
sample was subsequently illuminated for 30s with a >495 nm cut-off filter. The increase 
in Trp fluorescence, due to retinal release from MetaII (which parallels MetaII decay), 
was monitored, and after reaching a plateau, 50mM of hydroxylamine hydrochloride 
(pH 7) was added to confirm complete retinal release. The t1⁄2 values for the retinal 
release curves were determined by fitting the experimental data to single-exponential 
curves using Sigma Plot version 11.0 (Systat Software, Inc., Chicago, IL, USA). 
Chromophore re-entry after photoactivation measured by fluorescence spectroscopy  
The retinal re-entry process was monitored in real time by means of fluorescence 
spectroscopy. 2.5-fold retinal excess over pigment was added into the cuvette, after 
MetaII was completely decayed, and the changes in fluorescence intensity were 
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recorded. The volume of the concentrated retinal stock added to the protein sample was 
1% of the total sample volume. 
RESULTS 
UV-vis spectral characterization of purified WT and mutants 
WT, G90V and N55K mutants were purified from transfected COS-1 cells, and their 
UV-visible spectral properties, in either DM buffer (Figure 2) or bicelles buffer (Figure 
3), were compared. A summary of the main spectral features of the DM buffer samples, 
including λmax value of the visible chromophoric band, molar extinction coefficient (ε) 
and spectral ratio (A280/Aλmax) is shown in Table 1. N55K mutant showed a significantly 
higher A280/Aλmax ratio than WT and G90V mutant (Table 1), which implies lower 
chromophore regeneration. Because 9-cis-retinal, and not 11-cis-retinal, was used for 
the regeneration of the recombinant proteins, the WT, G90V and N55K mutants showed 
visible absorbance bands at 486 nm, 480 nm and 480 nm respectively. Upon 
illumination, G90V and N55K mutants showed incomplete conversion of the visible 
band to the 380 nm absorbing species with ~25% remaining absorbance at this 
wavelength indicating partial trapping of a photointermediate with a protonated SB 
linkage (Figure 2) 21,30. WT and G90V showed similar behavior upon illumination in 
bicelles buffer and in DM buffer. In the case of N55K in bicelles, this mutant showed an 
altered photobleaching pattern and additional illumination time was required to shift 
most of the visible band to 380 nm (Figure 3). 
DMPC/DHPC stabilization of ROS Rho 
DMPC/DHPC bicelles were previously used to increase the thermal stability of purified 
Rho obtained from ROS membranes 20,26,37. Here, ROS Rho, solubilized in DM (RhoDM), 
was purified and used merely as a standard control. In this case, Rho was used to 
confirm the effectiveness of DMPC/DHPC bicelles in maintaining protein stability. The 
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decay of the visible band (500 nm) was followed for RhoDM and Rho in bicelles 
(Rhobicelles) at 55ºC (Figure 4) and the t1/2 for the process were determined. T1/2 for 
Rhobicelles, at 55ºC (41.2±2.5 min) was about 9 fold larger than t1/2 for RhoDM (4.7±0.4 
min) indicating that DMPC/DHPC bicelles remarkably increase the thermal stability of 
Rho in comparison to the detergent-solubilized samples, in agreement with previous 
reports 21,26.  
Western blot of WT and G90V, N55K mutants in DM buffer and bicelles buffer 
Purified proteins were electrophoretically characterized by means of Western blot 
analysis (Figure 5).  WTbicelles showed higher mobility bands than WTDM and this could 
be tentatively assigned to oligomeric species of Rho (dimers and higher-order 
oligomers) although the contribution of protein aggregation cannot be ruled out. G90V 
showed a prominent characteristic 27KDa band that has been attributed to a truncated 
form of Rho. This band was detected both in DM and in bicelles. In the case of N55K 
mutant, N55Kbicelles  showed a less intense 27 kDa and an apparent increase in the high 
molecular mass species band when compared to N55KDM pattern.  
Thermal Stability of WT and G90V, N55K in DM and in DMPC/DHPC bicelles 
WT, G90V and N55K were eluted in either DM buffer or bicelles buffer and their 
thermal stability was determined at 37 ºC (Figure 6a). Higher temperature, 55ºC, was 
chosen in previous studies, but the decay process was too fast at this temperature for the 
t1/2 to be determined. At 37ºC, G90Vbicelles and N55Kbicelles showed enhanced thermal 
stability when compared to the DM-solubilized samples. Thermal decay process 
involves protein conformational changes, retinal isomerization and eventually 
hydrolysis of SB and chromophore release 20,38,39. We find that t1/2 of G90Vbicelles and 
N55Kbicelles suffers a 3 and 4 fold increase respectively when compared to the detergent-
solubilized samples (Figure 6a and Table 2). 
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Chromophore regeneration measurements 
The effect of DMPC/DHPC bicelles on pigment regeneration after photobleaching was 
analyzed for the purified proteins. The maximal extent of regeneration and the 
regeneration rate were the main factors analyzed (Figure 6b). WT regeneration extent 
was similar for WTbicelles and WTDM. However, G90Vbicelles showed 20% more 
chromophore regeneration than G90VDM. Remarkably, N55K exhibited a special 
behavior because, upon illumination, only 30-40% appeared to be photobleached and 
the added chromophore did not significantly improve N55K regeneration (Figure 6b and 
Table 2).  
Meta II decay measurements 
MetaII stability was studied by fluorescence spectroscopy, which measures retinal 
release upon sample illumination 36. Overall, the retinal release process was faster in 
bicelles than in DM samples. Under both conditions, t1/2 values for retinal release 
followed the order G90V >> WT > N55K, being G90V the slowest (Figure 6c, Figure 7 
and Table 2). This behavior may be tentatively associated with the clinical phenotypes 
caused by these mutations. In all cases, bicelles have decreased the t1/2 of the retinal 
release process for WT (25.4%), G90V (39.8%), and N55K (7.9%) compared with the 
same process in DM buffer  (Figure 6c, Figure 7 and Table 2). Hydroxylamine was 
added in order to confirm complete retinal release. No changes were detected for the 
samples in DM buffer (Figure 7A), but in bicelles environment both WT and G90V 
mutant showed slightly additional increase of Trp fluorescence emission which 
suggested additional retinal release from the binding pocket (Figure 7B). N55K did not 
show any increases and kept stable both in DM and bicelles environment (Figure 7A 
and B). This result is in contrast to that obtained in a previous study in which N55K was  
in PBS (pH 7.4) containing 0.05% DM 30. In that case hydroxylamine did cause an 
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increase in the fluorescence signal which points to a strong effect of buffer in the 
spectrofluorimetric measurements.  
Opsin conformational stability after retinal release 
WT and G90V, N55K mutants, in DM buffer or bicelles buffer, were analyzed by 
fluorescence spectroscopy in order to follow the potential ability of 9-cis-retinal to enter 
the opsin pocket after complete MetaII decay. Thus, 2.5 fold exogenous 9-cis-retinal 
was added, after complete retinal release (plateau in the fluorescence curve), in order to 
test whether this ligand could enter the binding pocket. WTDM showed only a minor 
reduction of Trp fluorescence, upon retinal addition, suggesting that the retinal ligand 
could not significantly enter its binding pocket (Figure 8A). A clear decrease in 
fluorescence could be detected in the case of WTbicelles, indicating that the exogenous 
chromophore could enter the binding pocket thus quenching Trp fluorescence (Figure 
8B). The structurally unstable mutants G90V and N55K showed a clear distinct 
behavior. Exogenous addition of 9-cis-retinal resulted in an important decrease of the 
fluorescence signal for G90VDM and a further decrease for G90Vbicelles (Figure 8). 
However no change was observed for the N55K either in DM or in bicelles suggesting 
that this mutation impaired retinal entrance to the binding pocket. Similar results were 
obtained when the experiments were carried out by using 11-cis- retinal (data not 
shown).  
DISCUSSION  
Rho mutants (both synthetic and naturally-occurring) have been widely studied to 
unravel the molecular mechanisms of GPCR activation and signaling, and the molecular 
mechanisms of RP retinal degenerative disease 16,40,41. Some of these mutations can 
cause structural instability and misfolding 42. The stability of visual photoreceptors, and 
other GPCRs, has been extensively studied, and several experimental factors, like 
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temperature, pH, salts, detergents, and lipids have been shown to affect the stability and 
function of these receptors 8,22,28,43–46. In spite of this, only limited information is 
available concerning the molecular causes of the structural instability of mutations in 
Rho associated with RP. In clear contrast with detergents, lipid bilayers have been 
shown to increase the stability and facilitate folding, assembly and function of 
membrane proteins 17,27,28. Here, we purified the newly reported unstable RP mutants, 
G90V and N55K, in DMPC/DHPC bicelles. This bicelles system has been proposed to 
support folding and thermal stability of Rho and opsin 26. Such a system has been used 
in solid-state NMR studies of membrane-associated molecules and its use extended to 
non-NMR-based biophysical studies of transmembrane proteins 27,47–49.  
The structural arrangement of Rho in DM and in bicelles show important differences.  
DM would form micelles to embed Rho, whereas DMPC and DHPC shaped bicelles 
that could better mimic the membrane environment (Figure 1). The UV-visible 
characterization of WT, N55K and G90V in DM detergent was done with 9-cis-retinal 
regenerated samples. The 9-cis isomer was used because it has been previously shown 
that this isomer can improve chromophore regeneration of Rho mutants 21. The visible 
bands of the WT and the mutants where blue-shifted, with regard to the 11-cis-retinal 
containing samples, due to the specific interaction of 9-cis-retinal with the amino acids 
in the binding pocket. N55K mutant showed higher A280/Aλmax than WT in DM buffer, 
which could imply lower chromophore stability during the purification process, as 
previously described 30. The two mutations studied, G90V and N55K, showed abnormal 
photobleaching behavior, in DM buffer, with incomplete conversion of the visible band 
upon illumination (Figure 2). In bicelles buffer, G90V showed WT-like behaviour but 
N55K showed an altered photobleaching pattern (Figure 3) indicating that bicelles 
stabilized either its dark state or a photointermediate conformation. Electrophoretic 
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analysis of the purified mutant proteins revealed differences in the intensities of bands 
that would correspond to dimeric (or higher-order oliogomeric) conformations that 
appeared to be favoured in bicelles.. Interestingly, G90V and N55K mutants showed the 
presence of lower bands in the 25-30 Kda range, particularly a 27 kDa band that has 
been attributed to a truncated form of opsin 50,51.  This behavior suggests that the 
mutants may have increased susceptibility to protein truncation which may be 
associated with a decreased conformational stability, and may be linked to the 
molecular phenotype underlying the pathological nature of the mutations.  
Thermal stability for the mutants at 37ºC has been clearly improved in the bicelles 
system. In particular, N55Kbicelles showed a 4-fold increase in thermal stability compared 
with N55KDM, at this temperature, meaning that bicelles provide conformational 
stability and protect the SB linkage from hydrolysis 39. Chromophore regeneration 
represents also an important index that reflects structural stability of Rho mutants. 
G90Vbicelles showed a 20% chromophore regeneration increase compared to G90VDM. 
From the fluorescence experiments, this mutant also showed increased retinal entry into 
the binding pocket long time after illumination, in the bicelles sample, suggesting that 
lipids play a role in the regeneration process by helping stabilize its optimal ligand-
binding conformation. In contrast, N55K did not show any improvement in 
chromophore regeneration which is consistent with the mutation impairing retinal 
release due to specific interactions at the transmembrane domain of the receptor. This 
trend would be maintained in the case of this mutant in the bicelles environment.  
In the MetaII decay experiment, after the sample was illuminated and the active MetaII 
conformation decayed, subsequent hydroxylamine addition resulted in additional 
fluorescence increase for WTbicelles and G90Dbicelles. This suggests that bicelles can 
increase the residence time of all-trans-retinal in the binding pocket thus extending the 
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available time for G-protein activation 6. On the contrary, N55K did not show any 
difference, after hydroxylamine addition, either in DM detergent or in bicelles buffer. 
We have previously reported that in PBS with 0.05% DM could  increase the 
fluorescence signal 30. Thus, the buffer conditions clearly influence the fluorescence 
assay.  
The fluorescence decrease upon retinal addition, after complete MetaII decay (Figure 8), 
would indicate that retinal can enter the retinal binding pocket although this does not 
demonstrate covalent binding to the opsin moiety. This suggests that bicelles help 
maintaining a stable opsin structure long time after complete retinal release process thus 
favoring retinal binding to the protein. Interestingly, N55K did not show any decrease, 
either in DM or in bicelles, and this is a differential effect only seen for this mutant that 
may be associated with the sector RP phenotype restricted mostly to the inferior 
quadrants of the retina 19. This unique N55K behavior may provide new clues that 
would guide us into deciphering the molecular mechanism of sector RP. We have 
previously associated this mechanism with different response to light by this mutant 30.  
Both the two mutations studied, N55K and G90D, correspond to amino acids which are 
facing to the protein interior and are mainly involved in helix-helix interactions. Thus, 
residues at 55 and 90 are not facing the lipid or involved in monomer-monomer 
interactions (Figure 9). Furthermore, the residues do not appear to significantly alter 
their orientation (or interactions) in the activated state of the receptor 12. 
In the case of N55K, this mutation is located at transmembrane helix 1 in a region closer 
to the cytoplasmic side of the protein where the G-protein activation process takes place. 
Three highly conserved residues, throughout the GPCRs superfamily, towards the cytoplasmic 
side of the receptor, N55 (98%), D83 (92%) and N302 (77%), define a region with intimate 
contact between TMs 1, 2 and 7, which involves also various highly conserved water molecules. 
In the N55K substitution, the Lys side-chain would interfere with these contacts and could form 
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a salt bridge with D83 (Figure 9). The G90V mutation affects an amino acid, at transmembrane 
helix 2, which is located towards the intradiscal domain of the protein that plays a structural role 
in the folding of the receptor and in the retinal binding process. The reported G90V mutant 
behavior suggests an important role for a functional water molecule present in the 
vicinity of E113 and the SB in the dark-state crystal structure of Rho 21. This water 
molecule binds to both the carbonyl backbone and one of the carboxyl oxygens of E113. 
The lack of a side-chain at G90 gives an empty volume that is filled with such a water 
molecule, whereas the hydrophobic chain in G90V would either not allow the water 
molecule to be accommodated or result in a smaller affinity.  The lack of the water 
molecule would alter the metarhodopsin I to MetaII transition energy landscape and 
would also decrease dark-state stability, in agreement with the present results 21.  
The influence of membrane morphology and composition on receptor structure and 
function is undoubtedly a key factor to take into account when analyzing the effect of 
mutations particularly of those associated with disease. We have reported a significant 
effect of DMPC/DHPC bicelles in the stabilization of Rho mutants associated with RP 
retinal disease. In the case of G90V, a significant increase in the chromophore thermal 
stability and regeneration was observed which is likely due to the stabilizing effect of 
the lipid bicelles on the opsin conformation of the mutant. The other studied mutant, 
N55K associated to the peculiar sector RP phenotype 30, shows also improved thermal 
stability but no improvement in its retinal regeneration ability. This would be due to the 
specificity imposed by the Lys introduced in the transmembrane domain of the 
photoreceptor protein 30 that would entrap the retinal molecule impairing efficient 
retinal regeneration after photobleaching. Overall, our results underscore the importance 
of the topological arrangement of lipids in stabilizing critical interhelical interactions 
and promoting favorable helical packing forces that would be absent in detergent-
solubilized samples. Further in-depth studies on the structural and energetic features of 
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the lipid-protein interactions are needed for deciphering the structural basis of the 
differential stability seen for Rho mutations. This knowledge is important in order to 
provide functionally-relevant structural information that can be useful in the 
development of targeted therapies towards retinal degenerative diseases. 
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Table 1. Spectroscopic properties of WT and RP mutants purified in DM buffer. 
aMean values of the visible λmax of WT and RP mutants G90V, N55K in DM buffer. 
bEach ε value was calculated with the equation: ε=(A/ARho)(A440Rho/A440) εRho. Where A 
is the absorbance at the λmax value, A440 is the absorbance at 440 nm after acid 
denaturation, and the  εRho is the molar extinction of Rho (42.7×103 M-1cm-1) 21. cThe 
A280/Amax ratio reflects the extent of chromophore regeneration. All values were 
determined from 3 independent experiments 
 
Opsin aλmax (nm) bε x 103 (M-1cm-1) cA280/A λmax 
WT 486±3 43.2±0.1 2.4±0.1 
G90V 480±3 34.1±0.5 3.0±0.3 
N55K 480±2 35.5±0.3 5.1±1.6 
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Table 2. Molecular properties of WT and RP mutants from thermal stability, 
chromophore regeneration and MetaII decay experiments in DM and bicelles. at1/2 of 
WT and G90V, N55K mutants in thermal bleaching experiments. Thermal decay 
experiments were run at 37°C. At the end of the thermal decay, 50 mM hydroxylamine 
(pH 7.0) was added to confirm complete decay. Curves were fit to an exponential decay 
function. bRegeneration percentage of WT and G90V, N55K mutants. Retinal was added 
before illumination and spectra were recorded every min after illuminating the samples 
for 30s. These experiments were run at 20ºC. cRetinal release t1/2 of WT and G90V, 
N55K mutants. Samples were stabilized for 10min in the dark and subsequently 
illuminated for 30s (λ> 495nm). Fluorescence increase was measured until the signal 
reached a plateau. 50mM hydroxylamine pH 7.0 was added to confirm complete retinal 
release. The t1/2 of the retinal release was determined from the exponential curves.  
 
 
 Buffer WT G90V N55K  
aThermal bleaching  
DM > 180 min 22.5±3.1  min 30.1±1.7  min 
bicelles > 180 min 64.1±3.7 min 123.5±2.6 min 
bRegeneration 
DM 91.8 ± 3.2% 70.8 ± 3.3% 11.7 ± 1.9% 
bicelles 88.9 ± 3.2% 96.2 ± 2.3% 16.9 ± 2.1% 
cMetaII decay 
DM 19.3±0.5 min 34.9±1.0 min 10.1±1.5min 
bicelles 14.4±1.7 min 21.0±2.6 min 9.3±2.1 min 
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Figures legends 
 
Figure 1. Schematic models for Rho in DM micelles and in DMPH/DHPC bicelles. 
(A) Schematic model for DM micelles with Rho. The hydrophobic tail of DM can wrap 
the hydrophobic transmembrane domain of the protein which is embedded in the core of 
the micelle. (B) Schematic model of DMPC-DHPC bicelles with embedded Rho.  
DMPC and DHPC form a bilayer structure.  
 
Figure 2. UV-vis characterization of WT, N55K and G90V in DM buffer. WT, G90V 
and N55K mutants were immunopurified in DM buffer with 0.05% DM. The spectra 
were measured at 20ºC. Illumination was carried out for 30s with a 150-watt power 
source equipped with an optic fiber guide using a >495nm cut-off filter to avoid 
photobleaching of the free retinal. (—) Dark state. (····) photobleached state;  inset, 
difference spectrum (dark-light). 
 
Figure 3. UV-vis difference spectra of the WT and N55K, G90V in bicelles before and 
after illumination. WT, G90V and N55K mutants were purified in bicelles buffer. The 
spectra were measured at 20ºC. (—) Dark state. (····), photobleached state. Illumination 
was carried out for 30s with a 150-watt power source equipped with an optic fiber guide 
using a >495nm cut-off filter to avoid photobleaching of the free retinal. Notably, 
N55Kbicelles showed only 20% photobleaching (a), illumination for a further 30s caused 
further Amax decay (b). 
 
Figure 4. DMPC/DHPC stabilization of Rho from ROS. A, Thermal Stability of Rho 
from ROS in either DM or bicelles at 55°C. Purified Rho was dissolved in either DM 
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buffer -- RhoDM () or in bicelles buffer -- Rhobicelles (o). Spectra were recorded at 55°C 
and normalized absorbance values at the Amax were plotted over time. Spectra were 
recorded every min. At the end of the thermal decay, 50 mM hydroxylamine (pH 7.0) 
was added to confirm complete decay. Curves were fit to an exponential decay function.  
 
Figure 5. Western blot of WT and G90V, N55K in either DM detergent or bicelles 
conditions. WT, G90V and N55K mutants were purified from COS-1 cells either in DM 
buffer or bicelles buffer respectively. The same amount of protein was loaded onto an 
SDS-PAGE gel, subject to electrophoresis and subsequently transferred to a 
nitrocellulose membrane for detection. WTbicelles and N55Kbicelles showed more higher-
molecular species than WTDM and N55KDM. The two mutants showed clear bands 
below the main opsin band that could correspond to truncated Rho or to non-
glyscosylated species.  
 
Figure 6. Conformational properties of WT and RP mutants from thermal stability, 
chromophore regeneration and MetaII decay experiments. WT and G90V, N55K 
were purified in DM buffer (black bar) and bicelles buffer (gray bar). a) t1/2 of WT, 
G90V and N55K mutants from thermal bleaching experiments at 37°C; b) chromophore 
regeneration percentage of WT and G90V, N55K mutants; c) t1/2 of WT and G90V, 
N55K mutants in MetaII decay experiments. The numerical values for the measured 
times are displayed in Table 2. The mean and error bars of three independent 
measurements are represented. 
 
Figure 7. MetaII decay for WT and G90V, N55K mutants. WT and G90V, N55K were 
purified in either DM buffer (panel A) or in bicelles buffer (panel B). The samples were 
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illuminated for 30s (> 495nm) after the dark-state fluorescence intensity was stabilized. 
After MetaII decay and once the fluorescence intensity reached plateau, 50mM 
hydroxylamine pH 7.0 was added to confirm complete retinal release.  
 
Figure 8. Retinal entry in photoactivated opsin . After fluorescence intensity reached a 
plateau, from MetaII decay experiment, for WT, N55K and G90V pigments purified 
either in DM buffer (panel A) or bicelles buffer (panel B), retinal was added (2.5 fold of 
exogenous retinal to the concentration of pigment) and mixed well to detect retinal entry 
into the binding pocket. WTbicelles and G90Vbicelles showed more fluorescence decrease 
than the DM samples, whereas N55Kbicelles did not show any change upon retinal 
addition.  
 
    
Figure 9. Structural model of Rho showing the sites of mutations. Lys at position 55 
(red) and Val at position 90 (yellow) are shown together with other relevant molecules, 
like retinal (green), Asp83 (blue) and water (magenta). Although the two mutations are 
located at the transmembrane domain of the protein, Lys55 is closer to the cytoplasmic 
domain where the G-protein activating function of the receptor takes place, whereas 
Val90 is closer to the retinal binding site and the intradiscal domain, a region of the 
protein that governs its folding and stability. Rho dark-state crystal structure (PDB id 
3C9L) was used and the image was created using PyMol (Schrodinger, LLC. The 
PyMOL Molecular Graphics System, Version 1.5).  
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